Previous company: Fugro (FUR)Next company: HAL Trust (HAL)
Galapagos
GLPG • AMX
Healthcare • Biotechnology
Market Cap
€2.0B
Founded
1999
Employees
1.4K
Headquarters
Mechelen, Belgium
Company Description
Galapagos N.V. is a biotechnology company focused on the discovery, development, and commercialisation of medicines in inflammation, fibrosis, and oncology.